This vertically integrated pharmaceutical company specializes in developing, manufacturing, and marketing a wide range of products across multiple therapeutic areas. Their key focus areas include oncology, blood-related products, nephrology, cardiology, gynecology, diabetology, and beta-lactam cephalosporins, along with vitamins and minerals. They also offer nutraceuticals and herbal products. The company's product portfolio encompasses various dosage forms such as injectables, suppositories, tablets, capsules, suspensions, syrups, ointments, emulsions, elixirs, ophthalmics, effervescent tablets, and dry powder. They have a strong global presence, participating in prominent industry events across regions like Europe and the Middle East. The company prioritizes quality and adheres to GMP certifications, further bolstering their commitment to delivering reliable pharmaceutical solutions.

This pharmaceutical company specializes in the development, manufacturing, and distribution of a wide range of healthcare products. They have a strong focus on affordability and accessibility, targeting therapeutic areas such as gastrointestinal, cardiovascular, women's health, and respiratory conditions. Their product portfolio includes APIs and finished dosage formulations (FDFs), with over 50 ANDAs and 25 DMFs available. They boast a WHO GMP certified manufacturing facility with a capacity of up to 450 tons per annum, serving clients across the globe in regions like North America, Europe, Asia, and Oceania. Their R&D efforts are dedicated to developing complex molecules and biosimilars, showcasing their commitment to innovation within the pharmaceutical industry.